8-M-PDOT

Research use only, not for human use.

8-M-PDOT (AH-002) is a selective and potent melatonin MT2 receptor agonist that also inhibits MT1 receptors. 8-M-PDOT exhibits anxiolytic activity and can be used to study MT2-induced neuropathic pain.

8-M-PDOT (AH-002) is a selective melatonin MT2 receptor agonist. 8-M-PDOT is 5.2-fold selective for MT2 over MT1 receptors. 8-M-PDOT binds human recombinant MT2 and MT2 receptors with pKi values of 8.23 and 8.95 respectively. 8-M-PDOT has anxiolytic-like activity.

——

8-M-PDOT (10 μg/μL; administrated into the dorsal striatum by bilateral cannulas; for 30 minutes; male Wistar rats) treatment shows anxiolytic-like effect.Animal Model:Male Wistar rats (280-320 g) with Rotenone Dosage:10 μg/μL Administration: Administrated into the dorsal striatum by bilateral cannulas; for 30 minutes Result:Increased percentage of time spent in the open arms and in the number of open arms entries.

——

Others

Other Targets

MT Receptor

——

——

134865-70-6

233.31

C14H19NO2

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (428.61 mM; Ultrasonic )

CCC(=O)NC1CCc2cccc(OC)c2C1

——

(-20℃)

With Ice Pack

≥ 2 years